England’s maternal RSV vaccination programme has produced the sort of result that makes a public health spreadsheet briefly consider optimism. A UK Health Security Agency study of nearly 300,000 babies born between September 2024 and March 2025 found that vaccination at least two weeks before birth gave 81.3% protection against hospitalisation for RSV. The data chart has asked everyone to remain calm while it enjoys being useful.
The study covered around 90% of births in England during that period and examined the first season of the vaccine programme. Protection rose to nearly 85% when vaccination happened at least four weeks before birth. Even vaccination 10 to 13 days before delivery was linked to a reduction in hospital admissions, giving the calendar an unusually constructive role in public health.
This is not an announcement that needs a dramatic soundtrack. It needs pregnant women to be offered the vaccine at the recommended point, clear information about what it does and a health service capable of making the process feel less like an escape room designed by a filing cabinet.
Uptake reached 55% during the study period. That is high enough for the figures to stand up straight, but low enough for the programme to know it still has work to do. The findings also matter for premature babies, who are particularly vulnerable to severe RSV infection. The study found good protection where there was sufficient time between vaccination and birth.
The underlying lesson is pleasingly unfashionable. A public health measure can be complicated in its research and straightforward in its purpose. Protect babies, explain the evidence, offer the vaccine on time and do not make people decode the instructions from a diagram that appears to have been folded during a power cut.
The evidence does not turn every uncertainty into certainty, and it does not replace proper advice from healthcare professionals. It does provide strong real world evidence that maternal RSV vaccination can reduce serious illness in newborns. Somewhere in the official data room, the chart has put on a tiny celebratory hat.
It is still waiting for approval from three committees, two subcommittees and a person whose entire job is to ask whether the hat has been properly risk assessed. At least the baby admissions are heading in the right direction.
Source: GOV.UK.
